Company intelligence
Egle Therapeutics
Modulating T-regulatory cells to balance immunity
Biotechnology Research
Paris, FR
52 employees
Founded 2020
1 public signals
About Egle Therapeutics
Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.
Verified activity
Signals from Egle Therapeutics
1 published signal